TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 87 filers reported holding TG THERAPEUTICS INC in Q4 2015. The put-call ratio across all filers is 3.76 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $5,480,000 | -30.9% | 1,178,520 | +15.1% | 0.00% | -50.0% |
| Q3 2016 | $7,927,000 | +35.0% | 1,024,196 | +5.7% | 0.00% | +100.0% |
| Q2 2016 | $5,872,000 | -29.8% | 968,987 | -1.3% | 0.00% | -50.0% |
| Q1 2016 | $8,363,000 | -26.9% | 981,545 | +2.4% | 0.00% | -33.3% |
| Q4 2015 | $11,439,000 | +21.8% | 958,833 | +2.9% | 0.00% | +50.0% |
| Q3 2015 | $9,395,000 | -39.1% | 932,054 | +0.2% | 0.00% | -50.0% |
| Q2 2015 | $15,434,000 | +23.1% | 930,330 | +14.9% | 0.00% | +33.3% |
| Q1 2015 | $12,534,000 | +3.6% | 809,701 | +6.0% | 0.00% | 0.0% |
| Q4 2014 | $12,097,000 | +105.7% | 763,724 | +38.6% | 0.00% | +50.0% |
| Q3 2014 | $5,881,000 | +10.5% | 551,171 | -2.8% | 0.00% | +100.0% |
| Q2 2014 | $5,324,000 | +68.1% | 566,987 | +23.5% | 0.00% | 0.0% |
| Q1 2014 | $3,168,000 | +81.1% | 459,061 | +2.4% | 0.00% | 0.0% |
| Q4 2013 | $1,749,000 | -21.7% | 448,445 | +1.2% | 0.00% | 0.0% |
| Q3 2013 | $2,233,000 | +20.8% | 443,035 | +53.1% | 0.00% | 0.0% |
| Q2 2013 | $1,849,000 | – | 289,316 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avoro Capital Advisors LLC | 5,229,619 | $74,261,000 | 3.55% |
| RA Capital Management | 2,472,344 | $35,107,000 | 2.69% |
| SENZAR ASSET MANAGEMENT, LLC | 475,918 | $6,758,000 | 2.13% |
| BRIDGER MANAGEMENT, LLC | 2,373,920 | $33,710,000 | 2.04% |
| Opaleye Management Inc. | 274,200 | $3,893,000 | 1.11% |
| Virtus ETF Advisers LLC | 89,920 | $1,277,000 | 1.11% |
| Eversept Partners, LP | 150,000 | $2,130,000 | 0.99% |
| Ghost Tree Capital, LLC | 300,000 | $4,260,000 | 0.86% |
| PURA VIDA INVESTMENTS, LLC | 50,000 | $710,000 | 0.42% |
| HIGHLAND CAPITAL MANAGEMENT LP | 464,391 | $6,595,000 | 0.34% |